| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2014 | Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. | Hsu, YH; Yao, J; Chan, LC; Wu, TJ; Hsu, JL; Fang, YF; Wei, Y; Wu, Y; Huang, WC; Liu, CL; Chang, YC; Wang, MY; Li, CW ; Shen, J; Chen, MK; Sahin, AA; Sood, A; Mills, GB; Yu, D; Hortobagyi, GN; Hung, MC | Cancer research 74(17), 4822-4835 | | | |
| 2006 | Doubly ortho-linked quinoxaline/diphenylfluorene hybrids as bipolar, fluorescent chameleons for optoelectronic applications | Chen, CT; Wei, Y; Lin, S; Moturu, MVRK; Chao, WS; Tao, YT ; Chien, CH | JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 128(34), 10992-10993 | | | |
| 2018 | Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. | Yang, Y; Li, CW; Chan, LC; Wei, Y; Hsu, JM; Xia, W; Cha, JH; Hou, J; Hsu, JL; Sun, L; Hung, MC | Cell research 28(8), 862-864 | | | |
| 2016 | GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. | Ko, HW; Lee, HH; Huo, L; Xia, W; Yang, CC; Hsu, JL; Li, LY; Lai, CC; Chan, LC; Cheng, CC; Labaff, AM; Liao, HW; Lim, SO; Li, CW ; Wei, Y; Nie, L; Yamaguchi, H; Hung, MC | Oncotarget 7(35), 57131-57144 | | | |
| 2014 | MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. | Thirumurthi, U; Shen, J; Xia, W; LaBaff, AM; Wei, Y; Li, CW; Chang, WC; Chen, CH; Lin, HK; Yu, D; Hung, MC | Science signaling 7(336), ra71 | | | |
| 2018 | Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1. | Cha, JH; Yang, WH; Xia, W; Wei, Y; Chan, LC; Lim, SO; Li, CW; Kim, T; Chang, SS; Lee, HH; Hsu, JL; Wang, HL; Kuo, CW; Chang, WC; Hadad, S; Purdie, CA; McCoy, AM; Cai, S; Tu, Y; Litton, JK; Mittendorf, EA; Moulder, SL; Symmans, WF; Thompson, AM; Piwnica-Worms, H; Chen, CH; Khoo, KH ; Hung, MC | Molecular cell 71(4), 606-620.e7 | | | |
| 2016 | Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation. | Wang, Y; Hsu, JM; Kang, Y; Wei, Y; Lee, PC; Chang, SJ; Hsu, YH; Hsu, JL; Wang, HL; Chang, WC; Li, CW ; Liao, HW; Chang, SS; Xia, W; Ko, HW; Chou, CK; Fleming, JB; Wang, H; Hwang, RF; Chen, Y; Qin, J; Hung, MC | Cancer research 76(23), 7049-7058 | | | |
| 2019 | Palmitoylation stabilizes PD-L1 to promote breast tumor growth. | Yang, Y; Hsu, JM; Sun, L; Chan, LC; Li, CW ; Hsu, JL; Wei, Y; Xia, W; Hou, J; Qiu, Y; Hung, MC | Cell research 29(1), 83-86 | | | |
| 2017 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression. | Jiao, S; Xia, W; Yamaguchi, H; Wei, Y; Chen, MK; Hsu, JM; Hsu, JL; Yu, WH; Du, Y; Lee, HH; Li, CW ; Chou, CK; Lim, SO; Chang, SS; Litton, J; Arun, B; Hortobagyi, GN; Hung, MC | Clinical cancer research : an official journal of the American Association for Cancer Research 23(14), 3711-3720 | | | |
